| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:873131087:1461 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:873131087:1461?format=raw |
LEADER: 01461cam a22004574a 4500
001 011982238-5
005 20090608145205.0
008 080702s2009 nyuaf b 001 0 eng
010 $a 2008940944
015 $aGBA891184$2bnb
016 7 $a101502391$2DNLM
016 7 $a014674471$2Uk
020 $a9781603273060 (alk. paper)
020 $a1603273069 (alk. paper)
020 $a9781603278799 (ebk.)
020 $a1603278796 (ebk.)
035 0 $aocn233933790
040 $aNLM$cNLM$dUKM$dBTCTA$dBAKER$dYDXCP$dBWX$dWYU$dCUS
042 $apcc
050 4 $aRC268.4$b.T45 2009
060 00 $a2009 D-964
060 10 $aQZ 202$bT277 2009
082 04 $a616.99407$222
245 00 $aTelomeres and telomerase in cancer /$cKeiko Hiyama, editor.
260 $aNew York :$bSpringer,$cc2009.
300 $axii, 373 p., [18] p. of plates :$bill. ;$c25 cm.
490 1 $aCancer drug discovery and development
504 $aIncludes bibliographical references and index.
650 12 $aCell Transformation, Neoplastic.
650 12 $aTelomere$xgenetics.
650 22 $aAntineoplastic Agents$xtherapeutic use.
650 22 $aNeoplasms$xdrug therapy.
650 22 $aTelomerase$xantagonists & inhibitors.
650 22 $aTelomere-Binding Proteins.
650 0 $aCancer$xMolecular aspects.
650 0 $aTelomerase.
650 0 $aTelomere.
700 1 $aHiyama, Keiko.
830 0 $aCancer drug discovery and development.
988 $a20090522
906 $0OCLC